Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
about
Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Polycystic ovarian syndrome: diagnosis and management.Immunologic and mass-spectrometric estimates of SHBG concentrations in healthy womenChanges in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomesAssessing and treating insulin resistance in women with polycystic ovarian syndromeThe role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction.The clinical biochemistry of obesity.Insulin resistance in patients with polycystic ovary syndrome.Adiponectin levels in obese and non-obese middle-aged African-American women.Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women.Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.Adiponectin and polycystic ovary syndrome.Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study.Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysisAdiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis.Indexes of Insulin Resistance in Hyperinsulinemic Polycystic Ovary Syndrome in a Macedonian Cohort of Women of Reproductive Age: A Cross-Sectional StudyInsulin resistance and the long-term consequences of polycystic ovary syndrome.The emerging roles of adiponectin in female reproductive system-associated disorders and pregnancy.Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria.Psychological distress, anger and quality of life in polycystic ovary syndrome: associations with biochemical, phenotypical andsocio-demographic factors.The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.Cardiovascular risk factors in polycystic ovary syndrome.Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones.Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study.Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes.Plasma sex hormone-binding globulin rather than corticosteroid-binding globulin is a marker of insulin resistance in obese adult males.Female fetus is associated with greater maternal insulin resistance in pregnancy.The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study.Obesity and insulin resistance in women with polycystic ovary syndrome.Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis.
P2860
Q30429162-6AFB9EBC-A7D7-4056-ABE4-AE1774195B70Q33569169-61CE0081-7BCF-4496-8E86-29DD58E80CCEQ33723471-5E8A4A47-45D3-4641-8AA4-232E9BB15225Q33788835-CA21B5CE-47D5-49F0-A92D-E17365D0D43DQ34258370-A11AA34C-E6D9-4BD8-B2B7-99EB76DCCE9CQ34878055-1BCDC04A-139B-4D99-AA46-335D7F9C6434Q35079458-C31475FE-40D4-4C11-BECC-0DB254511C4EQ35819237-56440150-3176-4DB0-912F-4790C535BCACQ35932352-59A691BE-3124-419C-B0B2-8EE6A964B589Q36031491-591104A9-ABE0-4DB7-A98D-682D89B3B360Q36091767-3EB30526-5B21-4D4E-8E1B-7A36463F8B6CQ36502941-768F12B1-E9EE-45C7-964B-FA7AF866C0D4Q36822774-5D9BC6B9-00F7-4BCB-B46D-357C03BD7EA6Q37133808-7E74F8C4-E7D1-4F58-B9A9-2E4D58611501Q37223571-4EA0B784-677F-4D18-94CF-760A3403BE09Q37406532-46312574-C553-491C-A34E-9BD341F7DBCDQ37523568-833E7CAF-9383-428E-8156-75F45F89840EQ37833622-522E04AC-C0D5-4D1E-B11B-82C3BD9A948FQ38070071-F133EA58-3CD2-4FC4-A4A2-F2AE6449641CQ38302430-A092A560-C5B7-4B86-AE9F-E43B6D48FADCQ38849555-12F1F356-F30C-4F67-BA70-2835485AEA64Q40196769-694A95C8-77F9-48D6-93B7-9B3527B317FCQ42471238-B097DC2E-7EDC-4819-B185-1BAD9A31F401Q44713621-8B6E186F-E248-4275-B341-A3A5E6A81CD6Q45173115-4D57F63F-91A0-4ED4-AACC-F4B4DBF6FA73Q45253540-CF9B14EF-D818-4A67-8609-D217A6D6C4EEQ46121424-C3D6506B-B9DF-4988-91A4-59840417F006Q46464037-F3DF6892-F54F-4F20-913A-6A9492EA22B4Q46470133-557EBDFF-C243-4640-A5EA-9D406FDF9946Q47241227-0511D9F1-01E6-44ED-8B67-544B2C36A87EQ47409637-B855B7E2-7CB5-49B0-85E9-16B82872B07BQ51121604-DD720F78-0674-49C6-BAB9-4CF3BAB1E41AQ51308164-FDBE9714-D237-4389-9BED-1AA5CA0A5A62Q51399542-F68D3BA3-03A3-402B-86BA-9701AAE2394EQ53134066-00C041A4-FC62-40C1-A05B-764AE355B28F
P2860
Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Glucose-to-insulin ratio rathe ...... ith polycystic ovary syndrome.
@ast
Glucose-to-insulin ratio rathe ...... ith polycystic ovary syndrome.
@en
type
label
Glucose-to-insulin ratio rathe ...... ith polycystic ovary syndrome.
@ast
Glucose-to-insulin ratio rathe ...... ith polycystic ovary syndrome.
@en
prefLabel
Glucose-to-insulin ratio rathe ...... ith polycystic ovary syndrome.
@ast
Glucose-to-insulin ratio rathe ...... ith polycystic ovary syndrome.
@en
P2093
P356
P1476
Glucose-to-insulin ratio rathe ...... ith polycystic ovary syndrome.
@en
P2093
Etienne Malvoisin
Hubert Bornet
Martine Laville
Michel Pugeat
Patrice Cousin
Pierre-Henri Ducluzeau
P304
P356
10.1210/JC.2003-030219
P407
P50
P577
2003-08-01T00:00:00Z